U.S. markets closed

Surgalign Holdings, Inc. (SRGA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
0.9937-0.0263 (-2.58%)
At close: 4:00PM EDT
0.9975 +0.00 (+0.38%)
After hours: 07:53PM EDT

Surgalign Holdings, Inc.

520 Lake Cook Road
Suite 315
Deerfield, IL 60015
United States
224 303 4651

IndustryMedical Devices
Full Time Employees197

Key Executives

NameTitlePayExercisedYear Born
Mr. Terry M. RichPres, CEO & Director646.35kN/A1968
Mr. Joshua H. DeRienzisChief Legal Officer & Corp. Sec.833.52kN/A1969
Mr. William Scott DurallChief Commercial Officer373.2kN/A1964
Mr. Christopher ThunanderVP & Chief Accounting OfficerN/AN/A1984
Mr. Douglas S. BireleyExec. VP of Marketing, R&DN/AN/AN/A
Mr. John N. VarelaExec. VP of Global OperationsN/AN/A1967
Mr. Enrico SangiorgioExec. VP of InternationalN/AN/AN/A
Mr. Olivier M. VisaPres of Global OEMN/AN/A1969
Mr. Bryan CornwallExec. VP of Research and Clinical AffairsN/AN/AN/A
Dr. Krzysztof Siemionow M.D., Ph.D.Chief Medical OfficerN/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Surgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spine implants worldwide. It offers products for thoracolumbar procedures, including Streamline TL Spinal Fixation system, a system for degenerative and complex spine procedures; and Streamline MIS Spinal Fixation system, a range of implants and instruments used via a percutaneous or mini-open approach; and interbody fusion devices, as well as products for cervical procedures, such as CervAlign ACP system, a comprehensive anterior cervical plate system; Fortilink-C IBF system, a cervical interbody fusion device that utilizes TETRAfuse 3D technology; and Streamline OCT system, a range of implants used in the occipito-cervico-thoracic posterior spine. The company also provides motion preservation systems comprising Coflex Interlaminar Stabilization device for the treatment of moderate to severe lumbar spinal stenosis in conjunction with decompression; HPS 2.0 Universal Fixation system, a pedicle screw system used for posterior stabilization of the thoracolumbar spine; SImmetry SI Joint Fusion system, a minimally invasive surgical implant system to decrease opioid use, pain, and disability. In addition, it develops Augmented Reality and Artificial Intelligence digital surgery platform to enable digital spine surgery. The company markets its products through independent spine and biomaterial distributors to hospitals, ambulatory surgery centers, and healthcare providers, as well as through direct sales force. It has a collaboration with Inteneural Networks for clinical neurosciences; and strategic agreement with Exactech, Inc. for the development and supply of biologic bone substitutes. The company was incorporated in 1997 and is headquartered in Deerfield, Illinois.

Corporate Governance

Surgalign Holdings, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.